The Scientific/Medical Director, Global Hematology Pipeline, Medical Affairs provides specialist medical and scientific input into strategic and operational medical affairs activities across the hematology pipeline (disease/asset strategy, scientific differentiation, value propositions, narratives/publication strategy, evidence generation, and HCP/provider interactions). Works closely with asset strategy, clinical development, value and evidence, and commercial teams.
Responsibilities:
- Support creation/execution of disease and asset strategies.
- Support pipeline medical evidence generation (company-sponsored studies, research collaborations, investigator-initiated studies).
- Lead early scientific narratives, messaging, and medical communications (congress planning, medical education, publication strategies/plans).
- Provide in-house medical expertise and coordinate scientific activities with internal/external stakeholders; may participate in due diligence/business development and translational strategy.
- Develop/execute medical expert engagement strategies; partner cross-functionally to incorporate internal/external perspectives.
- Provide scientific/medical education and act as a therapeutic area resource (conferences/literature).
- Assist with medical education programs/advisories/symposia; support scientific review/development/approval/execution/communication of sponsored/supported research.
- Coordinate scientific/medical activities with internal stakeholders (commercial, clinical operations, discovery, statistics, regulatory); serve as interface for key regulatory discussions.
- Ensure budgets, timelines, and compliance are factored into scientific activities.
Qualifications (Scientific Director): PhD or PharmD; additional post-doctorate highly preferred. 5β7+ years pharma or equivalent. 7β10 years Medical Affairs with global experience highly preferred. Multiple myeloma and cell therapies highly preferred. Knowledge of clinical trial methodology, data analysis, regulatory requirements; experience designing protocols. Proven cross-functional global leadership. Excellent oral/written English.